Literature DB >> 27926637

Pigmentation and Pregnancy: Knowing What Is Normal.

Amy Kalowitz Bieber1, Kathryn J Martires, Jennifer A Stein, Jane M Grant-Kels, Marcia S Driscoll, Miriam Keltz Pomeranz.   

Abstract

Changes in melanocytic nevi during pregnancy are frequently attributed to the new hormonal milieu and are dismissed without concern for malignancy. Recent studies suggest that pregnancy itself does not induce significant change in nevi, and delays in the assessment of changing moles may contribute to the often more advanced nature of melanomas diagnosed during or soon after pregnancy. Nevi on the breasts and abdomen can grow as a result of skin expansion, but studies have found no significant changes in nevi located in more stable areas such as the back or lower extremities. There is also insufficient evidence to support the notion that nevi darken during pregnancy. As such, any changing nevus that would raise concern for malignancy in a nonpregnant patient should do so in a pregnant patient as well. Pregnancy can, however, induce physiologic pigmentary changes that are often worrisome to both patients and physicians. These benign changes include melasma, pigmentary demarcation lines, secondary areola, and linea nigra as well as other less common findings. It is important for physicians to recognize these changes as physiologic to provide adequate reassurance to their patients and avoid unnecessary stress.

Entities:  

Mesh:

Year:  2017        PMID: 27926637     DOI: 10.1097/AOG.0000000000001806

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

Review 1.  Physiologic changes of pregnancy: A review of the literature.

Authors:  Catherine C Motosko; Amy Kalowitz Bieber; Miriam Keltz Pomeranz; Jennifer A Stein; Kathryn J Martires
Journal:  Int J Womens Dermatol       Date:  2017-10-21

Review 2.  Estrogen Receptors and Melanoma: A Review.

Authors:  Emi Dika; Annalisa Patrizi; Martina Lambertini; Nicholas Manuelpillai; Michelangelo Fiorentino; Annalisa Altimari; Manuela Ferracin; Mattia Lauriola; Enrica Fabbri; Elena Campione; Giulia Veronesi; Federica Scarfì
Journal:  Cells       Date:  2019-11-19       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.